Researchers identify genes that cause rare hidden cancer

by Garvan Institute of Medical ResearchIHC staining of human sarcoma cells (myxoid liposarcoma). Credit: Garvan Institute of Medical ResearchSeveral genes that cause sarcoma have been identified

Updated on: February 23,2024

Researchers identify genes that cause rare hidden cancer

by Garvan Institute of Medical ResearchIHC staining of human sarcoma cells (myxoid liposarcoma). Credit: Garvan Institute of Medical ResearchSeveral genes that cause sarcoma have been identified

Updated on:February 23,2024

Study: Immunotherapy costs drive increase in Medicare spending for outpatient cancer care at the end of life

by American Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives

Updated on: February 18,2024

Study: Immunotherapy costs drive increase in Medicare spending for outpatient cancer care at the end of life

by American Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives

Updated on:February 18,2024

Novel prognostic index to predict survival outcomes in gastric cancer patients

by Impact Journals LLCCancer-specific survival curve based on the inflammation-based prognostic index. Abbreviation: ICPI: inflammation based prognostic index. Credit:Oncotarget(2023). DOI

Updated on: January 30,2024

Novel prognostic index to predict survival outcomes in gastric cancer patients

by Impact Journals LLCCancer-specific survival curve based on the inflammation-based prognostic index. Abbreviation: ICPI: inflammation based prognostic index. Credit:Oncotarget(2023). DOI

Updated on:January 30,2024

Researchers present advance in re-treatment with CAR T therapy

by Perelman School of Medicine at the University of PennsylvaniaHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Researchers

Updated on: February 23,2024

Researchers present advance in re-treatment with CAR T therapy

by Perelman School of Medicine at the University of PennsylvaniaHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Researchers

Updated on:February 23,2024

Multigene testing replacing BRCA tests for breast cancer risk, researcher says

by Stanford University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014

Updated on: June 24,2024

Multigene testing replacing BRCA tests for breast cancer risk, researcher says

by Stanford University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014

Updated on:June 24,2024

Pregnancy poses no greater risk to breast cancer survivors

by Oxford University PressCredit: CC0 Public DomainA recent study published in theJournal of the National Cancer Instituteindicates that pregnancy does not incur a greater risk of rel

Updated on: March 06,2024

Pregnancy poses no greater risk to breast cancer survivors

by Oxford University PressCredit: CC0 Public DomainA recent study published in theJournal of the National Cancer Instituteindicates that pregnancy does not incur a greater risk of rel

Updated on:March 06,2024

Neuronal molecule makes prostate cancer more aggressive

byThomas Jefferson UniversityCredit: Unsplash/CC0 Public DomainProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers

Updated on: January 04,2024

Neuronal molecule makes prostate cancer more aggressive

byThomas Jefferson UniversityCredit: Unsplash/CC0 Public DomainProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers

Updated on:January 04,2024

New study shows recently diagnosed adult cancer survivors at higher risk for bone fractures

byAmerican Cancer SocietyAdult cancer survivors at increased risk for bone fractures. Credit: American Cancer SocietyAdult cancer survivors, particularly those diagnosed within five years and/or

Updated on: January 12,2024

New study shows recently diagnosed adult cancer survivors at higher risk for bone fractures

byAmerican Cancer SocietyAdult cancer survivors at increased risk for bone fractures. Credit: American Cancer SocietyAdult cancer survivors, particularly those diagnosed within five years and/or

Updated on:January 12,2024

Virus linked to cancer takes over 'cellular mail' to alter tumor environment

by University of North Carolina at Chapel Hill School of MedicineRyan P. McNamara, PhD, is a postdoctoral research associate at UNC Lineberger. Credit: University of North Carolina at Chapel Hill

Updated on: May 07,2024

Virus linked to cancer takes over 'cellular mail' to alter tumor environment

by University of North Carolina at Chapel Hill School of MedicineRyan P. McNamara, PhD, is a postdoctoral research associate at UNC Lineberger. Credit: University of North Carolina at Chapel Hill

Updated on:May 07,2024

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on: January 22,2024

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on:January 22,2024

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on: March 30,2024

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on:March 30,2024

Genomic deletions explain why some types of melanoma resist targeted therapies

byCenter for Genomic RegulationCredit: CC0 Public DomainMelanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to allevia

Updated on: April 28,2024

Genomic deletions explain why some types of melanoma resist targeted therapies

byCenter for Genomic RegulationCredit: CC0 Public DomainMelanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to allevia

Updated on:April 28,2024